Sunday, October 17, 2021

Tag: Pfizer

Five Mobile County hospitals to get Pfizer vaccine this week

Five hospitals in Mobile County will be part of the Alabama launch of the Pfizer COVID-19 vaccine, according to an official with the Mobile County Health Department.

The hospitals will give the initial doses to frontline healthcare workers

Dr. Scott Chavers, an epidemiologist with the Mobile County Health Department, told on Friday that Mobile Infirmary, University Hospital, USA Children’s and Women’s Hospital, Providence Hospital and Springhill Medical Center are on the state’s initial distribution lists.

He said the first phase of distribution, called “Phase 1a,” will include 5,800 initial vaccine doses that will be distributed to the Mobile County area and will be specifically given to healthcare workers.

The Alabama Department of Public Health, last week, confirmed the state is expected to receive about 40,000 initial doses overall.

“They were chosen because of their capability of storing the vaccine at the ultralow temperatures required for the Pfizer vaccine at

Read More
FDA OKs Emergency Use of Pfizer COVID-19 Vaccine

Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

The US Food and Drug Administration (FDA) has authorized Pfizer/BioNTech’s COVID-19 vaccine for emergency use in people 16 years of age and older. 

The much-anticipated emergency use authorization (EUA) of this vaccine — the first such approval in the United States — was greeted with optimism by infectious disease and pulmonary experts, although unanswered questions remain regarding use in people with allergic hypersensitivity, safety in pregnant women, and how smooth distribution will be.

Dr William Schaffner

“I am delighted. This is a first, firm step on a long path to getting this COVID pandemic under control,” William Schaffner, MD, professor of infectious diseases at the Vanderbilt University School of Medicine in Nashville, Tennessee, said in an interview with Medscape Medical News.

The FDA gave the green light after the December 10 recommendation from the agency’s Vaccines and

Read More
First coronavirus vaccine shipments leave Pfizer facility, head to states

But even as state officials scrambled to distribute the first doses, they criticized the federal government for a lack of transparency and limited financial help, warning that both could hamper efforts to quickly vaccinate the most vulnerable populations, including health-care workers and the elderly.

As the vaccine doses made their way to hospitals Sunday, Centers for Disease Control and Prevention Director Robert Redfield gave the final nod, greenlighting the decision to recommend Pfizer’s vaccine for those 16 and older.

Additionally, the governors of California, Washington, Oregon and Nevada announced Sunday that an independent review of the Pfizer vaccine found it was safe for public use. They said the vaccine was on the way but did not give a specific estimate for when the first shots would be given.

As the vaccine arrived at a Louisville hub for distribution across the east coast Sunday, Kentucky Gov. Andy Beshear (D) moved up

Read More
First COVID-19 vaccine shipments leave Pfizer plant in Michigan

The first shipments of Pfizer’s COVID-19 vaccines were reportedly transported from the pharmaceutical company’s facility in Portage, Michigan early Sunday.

According to CNN, roughly 184,275 vials of the vaccine, spread across about 190 boxes, left the plant in freight trucks. The vials will reportedly be delivered to every state by the start of the coming week.

The company is also reportedly sending out an additional 390,000 vials on Monday.

The development comes several days after the Food and Drug Administration (FDA) granted emergency authorization to the vaccine, which was produced by Pfizer and BioNTech, on Friday.

A day later, a panel of advisers for the Centers for Disease Control and Prevention (CDC) also voted to recommend the medication be administered to those in the country ages 16 and older. The director of the CDC is expected to accept that recommendation, clearing the way for vaccines to be administered. The vaccine

Read More
ACIP votes to recommend Pfizer vaccine for those 16 and older

The vote was 11 in favor, with three members not voting because of conflicts of interest.

“I know we’re going to have very tough and sad times ahead because of the surge and a limited vaccine supply, but I am really hopeful that this is the beginning of the end of the coronavirus pandemic,” said Peter G. Szilagyi, a professor of pediatrics at the University of California at Los Angeles.

The panel’s recommendation is “a hugely important step,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases.

Beth Bell, a global health expert at the University of Washington who leads the panel’s coronavirus vaccine work group, referred to public concerns about the new vaccine and said she would get a shot when it is her turn and would recommend it for her family. Several members said they would do the same.

While Bell applauded the

Read More
FDA authorizes Pfizer vaccine; Trump tweets


As the COVID-19 vaccine rolls out, people are wondering if they will be required to take it to go back to work. History provides some clues.


Ten months and 20 days after the first case of COVID-19 was confirmed in the United States, the Food and Drug Administration has granted emergency authorization to a vaccine that data shows is highly effective at preventing a disease that has killed nearly 300,000 Americans. 

The vaccine, from Pfizer and its German partner BioNTech, was developed at a historically swift pace, besting early estimates that projected it would be a year or more before a COVID-19 vaccine would be authorized.

Cutting-edge science and extraordinary funding helped compress that timeline, leading to a vaccine believed to be more than 90% effective in blocking the symptoms of COVID-19 and that has shown no major, unexpected safety problems.

“This is a light at the

Read More
CDC panel recommends moving forward with Pfizer vaccine

A panel of advisers to the Centers for Disease Control and Prevention (CDC) voted Saturday to recommend that the coronavirus vaccine created by Pfizer and BioNTech be administered to people age 16 and up, moving one step closer to getting the shot into the arms of millions of Americans.

a close up of a bottle: CDC panel recommends moving forward with Pfizer vaccine

© getty
CDC panel recommends moving forward with Pfizer vaccine

The CDC’s Advisory Committee on Immunization Practices cast its vote during an emergency session on Saturday. The vaccine cannot be administered until CDC Director Robert Redfield approves the recommendation, though that is anticipated to occur later this weekend.

The vote comes a day after the Food and Drug Administration (FDA) authorized the Pfizer vaccine candidate for emergency use in the U.S.

The panel made a series of recommendations to health care providers, including monitoring people with allergies for 30 minutes after an injection.

The CDC vaccine panel recommended that health

Read More
Pfizer vaccine distribution has begun; ICU beds limited

A day after authorizing the first COVID-19 vaccine in the U.S., federal officials said Saturday that distribution has begun.

“As I speak today, right now, vaccines are being packaged,” Gen. Gustave Perna, co-leader of Operation Warp Speed in charge of logistics, said Saturday. “Tomorrow morning, vaccines will start rolling from manufacturing to distribution hubs. By Monday, vaccines will be received.”

The vaccine will be sent to to 636 locations nationwide this week, with 145 sites receiving doses Monday, 425 on Tuesday and the final 66 on Wednesday, Perna said.

No vaccine was prepositioned in advance, Perna said. “We did not want to presume” emergency use authorization, he said. “Under no circumstances did we want to get ahead of the great FDA and their decision making.”

Earlier Saturday, Food and Drug Administration officials reassured the American public that the agency did not cut corners in its review and urged people to

Read More
F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away

The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days.

The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Other authorizations, including by the European Union, are expected within weeks.

The F.D.A.’s decision followed an extraordinary sequence of events on Friday morning when the White House chief of staff, Mark Meadows, told the F.D.A. commissioner, Dr. Stephen Hahn, to consider looking for his next job if he didn’t get the emergency approval done on Friday, according to a senior administration official who spoke on condition of anonymity because he was not authorized

Read More
Trump Pushes For Fast Pfizer Approval As Other Vaccines Hit Snags

President Donald Trump on Friday piled pressure on the US drug regulator to quickly approve the Pfizer-BioNTech Covid-19 vaccine as America readied to roll out mass immunizations.

The Washington Post reported that the White House told the Food and Drug Administration (FDA) chief Stephen Hahn to submit his resignation if the agency does not clear the vaccine by the end of the day.

Hahn later disputed the characterization of the call, but the alleged threat came as Trump tweeted that the agency was a “big, old, slow turtle” and told Hahn to get the “dam” vaccines out immediately.

A woman walks past a costume rental store, with Santa Claus outfits outside, on December 10, 2020 in Paris as France is on a second lockdown in a bid to contain the spread of Covid-19 pandemic caused by the novel coronavirus A woman walks past a costume rental store, with Santa Claus outfits outside, on December 10, 2020 in Paris as France is on a second lockdown in a bid to contain the spread of Covid-19 pandemic caused by the novel coronavirus Photo: AFP / JOEL SAGET

An expert committee had already voted

Read More